At International Milk bank (IMB), we have an uncompromising commitment to quality, safety, and integrity as we provide humanity with a reliable, safe, and abundant source of human milk.
Setting a new standardization of human milk processing
Ensuring all our human milk and milk products meet the highest standards for quality.
Operating from an expertise that ensures the health and well-being of the recipient comes first.
Our goal is to provide human milk to babies whose mothers may not be able to meet their babies’ needs. IMB’s safety testing, screening and processing of milk products will allow us to dispense safe, Donor human milk, so mothers can share the joy with one another.
Our mission is to provide a reliable, safe and abundant source of nutrition for infants and especially premature babies. Our unique treatment, qualification, processing and controls will make International Milk Bank the leading choice for these at-risk babies. Due to our unprecedented supply of human milk, IMB will be able to end the national shortage and embark to offer this same quality of human breast milk to meet the international cry for help.
Our mission addresses a serious need for the healthy development of infants. The U.S. Surgeon General, in a call for action to support breastfeeding, spotlighted the challenge and IMB has embraced to make a difference.
“Identify and address obstacles to greater availability of safe banked donor milk for fragile infants.” Growing evidence supports the role of donated human milk in assisting infants with special needs, such as infants in newborn intensive care units who are unable to receive their own mothers’ milk, to achieve the best possible health outcome. In these situations, use of banked donor milk may protect the infant from the risks that might result from not breastfeeding. Unfortunately, demand for donor milk outpaces supply because of logistical challenges related to transportation of donated milk, the lack of clarity in oversight, and the high cost of providing banked human milk. A national strategy is needed to efficaciously and effectively address the issues involved in providing banked donor milk to vulnerable infant populations.”
IMB will be among the first to offer commercially sterile human milk free from dangerous Bacillus cereus spores. Nothing short of commercial sterility is acceptable in the neonatal intensive care unit. We are positioned to address this important need to the United States, and as a first mover offer this rich commodity to the international market as well.